During GLP-1 medication usage, consumers need to focus on muscle mass retention, minimizing GI discomfort and hydration
Data statistics are shown in Figure 8E
If youre open to compounded, the real question is your tolerance for a product the FDA hasnt reviewed
Resources Down syndrome General Folate (NIH Office of Dietary Supplements) Folate (folic acid) (Mayo Clinic) Vitamin B12 (NIH Office of Dietary Supplements) Vitamin B12 (Mayo Clinic) References Yassaee F, Hadadianpour S
Heres what youll learn: Why endometriosis is not just painful periods , but a full-body inflammatory disease The shocking statistic that women with endometriosis may have a 4060% higher risk of cardiovascular disease How Ozempic and other GLP-1 medications may help reduce inflammatory signaling Why GLP-1 levels may already be altered in women with endometriosis The connection between endometriosis pain, cytokines, prostaglandins, mast cells, and immune dysfunction How adhesions, fibrosis, and scar tissue may contribute to worsening pelvic pain Why some women report less endometriosis pain after starting semaglutide or tirzepatide How GLP-1s may support blood sugar stability, insulin sensitivity, and reduced visceral fat Why 80% of women with endometriosis report fatigue as a major symptom The possible connection between mitochondrial dysfunction, brain fog, and endo fatigue Which GLP-1 medications are most commonly discussed: Ozempic, semaglutide, tirzepatide, liraglutide, and exenatide Why GLP-1s are not a cure for endometriosis , but may be one tool in a broader strategy What to discuss with your doctor if you have endometriosis symptoms plus insulin resistance, PCOS, or metabolic syndrome Why endo belly, blood sugar crashes, and inflammation may all be connected How nutrition, sleep, omega-3s, NAC, and pelvic floor physical therapy fit into the bigger picture How Ozempic and GLP-1 Medications May Affect Endometriosis Pain and Symptoms One of the most important takeaways from this episode is that GLP-1 medications may influence multiple pathways involved in endometriosis symptoms and pain
The growth in the GLP-1 receptor agonist cardiovascular therapy market is being driven by mounting clinical evidence that shows GLP-1 receptor agonists can lower severe adverse cardiovascular events in patients with existing ASCVD
